Compound Information
|
ID |
443 |
TrivialName |
notoginsenoside SY4 |
Type |
C17-side chain varied |
MF |
C₄₃H₇₄O₁₄ |
MolecularWeight |
815.051 |
IUPACName |
NT |
m/z |
NT |
Retention Time |
NT |
CCS |
NT |
Adducts |
NT |
Isomeric SMILES |
CC1(C)[C@@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)[C@@H](O)[C@H](O)[C@@H](CO)O2)CC[C@@]4(C)C1CC[C@]5(C)C4C[C@@H](O)C6[C@@]5(C)CCC6[C@](O)(C)C/C=C/C(C)(OC)C |
Canonical SMILES |
COC(C)(C)C=CCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C |
Source |
PN |
Functions |
Neuromastogenic and acetylcholinesterase (AChE) inhibitory activities |
Year |
2020 |
References |
Yang et al. (2020)
|
Structure |
|